Equities

Runben Biotechnology Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Runben Biotechnology Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)23.23
  • Today's Change-0.38 / -1.61%
  • Shares traded2.13m
  • 1 Year change-15.89%
  • Beta--
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Runben Biotechnology Co Ltd is a China-based company mainly engaged in the production and sales of mosquito repellent products and daily necessities. The Company's main products can be divided into three sectors: mosquito repellent products, baby care products and essential oil products. The Company's principal products include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, skin care cream and others. The Company mainly provides products to consumers through Internet sales models such as online direct sales, online platform distribution, and online platform agency sales. The Company mainly conducts its businesses in the domestic market.

  • Revenue in CNY (TTM)1.52bn
  • Net income in CNY305.33m
  • Incorporated2013
  • Employees921.00
  • Location
    Runben Biotechnology Co Ltd#3 Xinzhuang 5th RoadEconomic Technology Development ZoneGUANGZHOU 510000ChinaCHN
  • Phone+86 2 038398399
  • Fax+86 2 038398366
  • Websitehttps://www.runben.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Phoenix Enterprise Group Co Ltd2.19bn-73.03m4.82bn1.59k--3.07--2.20-0.1411-0.14114.264.150.62788.545.071,382,979.00-2.08-1.34-3.08-1.8213.7915.09-3.31-2.241.29--0.1499--26.0317.59-407.09--47.57--
Shuhua Sports Co Ltd1.52bn75.07m4.95bn2.26k62.634.04--3.260.19320.19323.803.000.76473.965.08673,574.303.776.165.698.7328.2929.324.948.041.39--0.21390.34-0.36391.22-29.96-9.27-17.40--
Thunder Tiger Corp308.83m31.12m4.97bn208.00156.1212.0089.9216.080.9480.9489.4112.330.51151.089.86--5.041.507.102.4137.3438.749.852.351.56--0.24510.0026.398.83377.36---0.1833--
Dream International Ltd5.07bn677.67m5.16bn28.70k7.611.456.241.021.131.138.475.951.164.627.10199,820.6015.5113.0519.6617.5821.3019.9113.3710.622.48137.340.02744.511.826.52-11.018.512.4435.78
Merida Industry Co Ltd6.07bn-224.94m5.40bn3.77k--1.29--0.8895-3.43-3.4392.1463.550.70772.607.47---2.807.54-4.3211.4314.7016.47-3.968.900.7110.57030.260873.468.700.9654-141.32---17.84-0.9711
Happinet Corp19.03bn492.10m5.90bn1.12k11.111.9410.140.31244.06244.069,440.181,395.692.7931.114.95374,655,400.007.214.8816.899.0512.1410.982.591.471.34--0.0042.503.989.332.7840.7625.4121.06
Giant Manufacturing Co Ltd13.53bn12.11m7.55bn--673.021.0312.420.5580.13020.1302155.3484.870.81112.145.43--0.26095.870.480911.9418.4322.250.32165.790.98661.490.285459.06-7.372.35-62.84-17.83-5.99-13.55
Fusheng Precision Co Ltd6.55bn728.82m8.14bn--11.232.698.081.2423.6423.64212.6198.621.215.857.06--14.7716.5625.2929.2225.7624.6612.1712.481.47--0.108967.2916.3610.5357.8711.7713.2219.69
Johnson Health Tech Co Ltd11.50bn623.74m9.20bn5.08k14.783.709.430.809.349.34172.3637.281.231.934.66--6.662.3812.865.3751.3247.375.422.360.7691--0.636251.0525.5213.50242.3613.460.798723.33
Runben Biotechnology Co Ltd1.52bn305.33m9.40bn921.0030.784.33--6.190.75470.75473.755.370.6715.0463.221,648,408.0013.49--14.47--57.11--20.11--11.47--0.0008--27.61--32.80------
Butong Group1.39bn78.93m10.42bn641.00132.01492.46103.297.470.9840.98417.380.2638----------------49.92--5.66--0.70888.550.9539--46.56--114.94------
Noritsu Koki Co Ltd5.17bn747.94m11.24bn1.24k15.111.0911.142.17151.13151.121,062.602,100.630.38962.507.0292,296,210.005.63--6.40--49.83--14.46--2.941,998.460.1383--16.37--39.51------
Tomy Co Ltd11.94bn518.65m11.84bn2.50k21.732.2412.590.9915128.64128.642,959.161,247.791.506.215.91105,729,600.006.526.309.669.1640.2639.954.345.141.771,169.050.069336.6820.128.7166.7029.4019.1416.36
Data as of Feb 13 2026. Currency figures normalised to Runben Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

27.72%Per cent of shares held by top holders
HolderShares% Held
Yinhua Fund Management Co., Ltd.as of 30 Jun 20254.40m7.25%
Guotai Asset Management Co., Ltd.as of 30 Jun 20252.11m3.47%
Bosera Asset Management Co., Ltd.as of 30 Jun 20251.86m3.07%
China Asset Management Co., Ltd.as of 30 Jun 20251.71m2.82%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20251.52m2.50%
Orient Securities Asset Management Co. Ltd.as of 30 Jun 20251.25m2.06%
UBS SDIC Fund Management Co., Ltd.as of 30 Jun 20251.14m1.88%
China Southern Asset Management Co., Ltd.as of 30 Jun 20251.09m1.80%
CPIC Fund Management Co. Ltd.as of 30 Jun 20251.06m1.75%
Minsheng Royal Fund Management Co., Ltd.as of 30 Jun 2025673.40k1.11%
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.